120.40SEK+1.52%Mkt Cap: 2.94B SEKP/E: 21.92Last update: 2026-05-13
CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hemat…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)21.92
P/E (Forward)14.99
PEG—
P/B3.21
P/S4.02
EV/EBITDA14.07
EV/Revenue3.74
EPS (TTM)5.62
EPS (Forward)8.22
Cash Flow & Leverage
FCF Yield3.06%
FCF Margin12.31%
Operating CF200.53M SEK
CapEx (TTM)86.27M SEK
Net Debt/EBITDA-1.07
Net Debt-207.79M SEK
Technical
SMA 50142.25 (-15.4%)
SMA 200158.65 (-24.1%)
Beta0.95
S&P 52W Chg24.23%
Avg Vol (30d)53.95K
Avg Vol (10d)42.65K
Technical Indicators
RSI (14)33.5
MACD-8.2561
MACD Signal-7.4291
MACD Hist.-0.8270
BB Upper168.91 SEK
BB Middle133.62 SEK
BB Lower98.33 SEK
BB Width52.82%
ATR (14)5.639 SEK
Vol Ratio (20d)0.45x
52W Range
117.603% of range202.50
52W High202.50 SEK
52W Low117.60 SEK
Profitability
Gross Margin68.50%
EBITDA Margin26.57%
Profit Margin20.17%
Oper. Margin17.12%
ROE17.25%
ROA13.98%
Revenue Growth-14.60%
Earnings Growth-45.80%
Balance Sheet
Debt/Equity0.03
Current Ratio3.80
Quick Ratio2.82
Book Value/Sh38.33 SEK
Cash/Share9.652 SEK
Dividends
Fwd Div Rate2.750 SEK
Trail. Div Rate2.750 SEK
Div. Yield2.23%
5Y Avg Yield0.95%
Payout Ratio44.48%
Ex-Div DateApr 29, 2026
Pay Date—
Ownership
Shares Out.23.85M
Float19.56M
Insiders16.92%
Institutions73.82%
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)179.00 SEK
Target Range140.00 SEK – 211.00 SEK
# Analysts4
Company
Market Cap2.94B SEK
Enterprise Value2.73B SEK
Revenue (TTM)730.59M SEK
Gross Profit519.88M SEK
Net Income (TTM)153.08M SEK
Revenue/Share30.63 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees241
Last Price120.40 SEK
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—